|
Symbol |
Name |
Market Cap |
Exchange |
Z-Score |
![Company Website](link.gif) | ABT ![Inactive Symbol](dead.gif) | Abbott Laboratories | $76.1B | NYSE | 2.9502 |
![Company Website](link.gif) | ACST ![Inactive Symbol](dead.gif) | Acasti Pharma Inc | $13.5M | NASDAQ | |
![Company Website](link.gif) | ACET ![Inactive Symbol](dead.gif) | Aceto Corporation | $424.6M | NASDAQ | 3.1677 |
![Company Website](link.gif) | ADMP ![Inactive Symbol](dead.gif) | Adamis Pharmaceuticals Corp | $78.3M | NASDAQ | 0.6003 |
![Company Website](link.gif) | AEGR ![Inactive Symbol](dead.gif) | Aegerion Pharmaceuticals, Inc. | $56.6M | NASDAQ | -0.2894 |
![Company Website](link.gif) | AKRX ![Inactive Symbol](dead.gif) | Akorn, Inc. | $4.2B | NASDAQ | 3.2681 |
![Company Website](link.gif) | AMAG ![Inactive Symbol](dead.gif) | AMAG Pharmaceuticals, Inc. | $667.9M | NASDAQ | 0.499 |
![Company Website](link.gif) | FOLD ![Inactive Symbol](dead.gif) | Amicus Therapeutics, Inc. | $1.0B | NASDAQ | 0.1665 |
![Company Website](link.gif) | AMPH ![Inactive Symbol](dead.gif) | Amphastar Pharmaceuticals Inc | $743.8M | NASDAQ | 5.7008 |
![Company Website](link.gif) | APRI ![Inactive Symbol](dead.gif) | Apricus Biosciences Inc | $14.0M | NASDAQ | -94.2731 |
![Company Website](link.gif) | AQXP ![Inactive Symbol](dead.gif) | Aquinox Pharmaceuticals Inc | $251.4M | NASDAQ | 14.906 |
![Company Website](link.gif) | ARLZ ![Inactive Symbol](dead.gif) | Aralez Pharmaceuticals Inc | $102.7M | NASDAQ | |
![Company Website](link.gif) | AZN ![Inactive Symbol](dead.gif) | AstraZeneca plc (ADR) | $42.8B | NYSE | 1.0932 |
![Company Website](link.gif) | BDSI ![Inactive Symbol](dead.gif) | BioDelivery Sciences International, Inc. | $101.8M | NASDAQ | -6.605 |
![Company Website](link.gif) | BLFS ![Inactive Symbol](dead.gif) | BioLife Solutions Inc | $29.1M | NASDAQ | -7.3448 |
![Company Website](link.gif) | BMY ![Inactive Symbol](dead.gif) | Bristol-Myers Squibb Co | $90.8B | NYSE | 5.2435 |
![Company Website](link.gif) | CBM ![Inactive Symbol](dead.gif) | Cambrex Corporation | $1.7B | NYSE | 6.7914 |
![Company Website](link.gif) | CTLT ![Inactive Symbol](dead.gif) | Catalent Inc | $4.0B | NYSE | 1.2594 |
![Company Website](link.gif) | CLRB ![Inactive Symbol](dead.gif) | Cellectar Biosciences Inc | $17.2M | NASDAQ | 0.166 |
![Company Website](link.gif) | CPHR ![Inactive Symbol](dead.gif) | Cipher Pharmaceuticals Inc | $77.8M | NASDAQ | |
![Company Website](link.gif) | COLL ![Inactive Symbol](dead.gif) | Collegium Pharmaceutical Inc | $221.7M | NASDAQ | 3.9724 |
![Company Website](link.gif) | CLCD ![Inactive Symbol](dead.gif) | CoLucid Pharmaceuticals Inc | $895.6M | NASDAQ | 76.7748 |
![Company Website](link.gif) | CXRX ![Inactive Symbol](dead.gif) | Concordia International Corp | $76.1M | NASDAQ | |
![Company Website](link.gif) | CORT ![Inactive Symbol](dead.gif) | Corcept Therapeutics Incorporated | $1.2B | NASDAQ | 20.6599 |
![Company Website](link.gif) | CORI ![Inactive Symbol](dead.gif) | Corium International Inc | $165.1M | NASDAQ | -0.7443 |
![Company Website](link.gif) | RDY ![Inactive Symbol](dead.gif) | Dr.Reddy's Laboratories Ltd (ADR) | $6.9B | NYSE | 1.7863 |
![Company Website](link.gif) | LLY ![Inactive Symbol](dead.gif) | Eli Lilly and Co | $88.2B | NYSE | 3.3818 |
![Company Website](link.gif) | EVOK ![Inactive Symbol](dead.gif) | Evoke Pharma Inc | $39.5M | NASDAQ | -3.5394 |
![Company Website](link.gif) | EYEG ![Inactive Symbol](dead.gif) | Eyegate Pharmaceuticals Inc | $18.5M | NASDAQ | -10.5269 |
![Company Website](link.gif) | GALE ![Inactive Symbol](dead.gif) | Galena Biopharma Inc | $21.2M | NASDAQ | -5.9726 |
![Company Website](link.gif) | GSK ![Inactive Symbol](dead.gif) | GlaxoSmithKline plc (ADR) | $107.1B | NYSE | 1.4541 |
![Company Website](link.gif) | HSGX ![Inactive Symbol](dead.gif) | Histogenics Corp | $22.3M | NASDAQ | -5.564 |
![Company Website](link.gif) | HZNP ![Inactive Symbol](dead.gif) | Horizon Pharma PLC | $1.7B | NASDAQ | 0.4013 |
![Company Website](link.gif) | IBIO ![Inactive Symbol](dead.gif) | Ibio Inc | $33.9M | NYSE MKT | -0.5538 |
![Company Website](link.gif) | IMNP ![Inactive Symbol](dead.gif) | Immune Pharmaceuticals Inc | $23.1M | NASDAQ | -1.9669 |
![Company Website](link.gif) | IPXL ![Inactive Symbol](dead.gif) | Impax Laboratories Inc | $1.3B | NASDAQ | 1.378 |
![Company Website](link.gif) | INNL ![Inactive Symbol](dead.gif) | Innocoll Holdings PLC | $64.1M | NASDAQ | -6.2078 |
![Company Website](link.gif) | INVA ![Inactive Symbol](dead.gif) | Innoviva Inc | $1.3B | NASDAQ | -4.0494 |
![Company Website](link.gif) | IPCI ![Inactive Symbol](dead.gif) | IntelliPharmaCeutics Intl Inc (USA) | $52.6M | NASDAQ | -5.9623 |
![Company Website](link.gif) | JNJ ![Inactive Symbol](dead.gif) | Johnson & Johnson | $336.3B | NYSE | 4.7797 |
![Company Website](link.gif) | JNP ![Inactive Symbol](dead.gif) | Juniper Pharmaceuticals Inc | $47.7M | NASDAQ | -2.7635 |
![Company Website](link.gif) | LCI ![Inactive Symbol](dead.gif) | Lannett Company, Inc. | $841.7M | NYSE | 1.1642 |
![Company Website](link.gif) | MRNS ![Inactive Symbol](dead.gif) | Marinus Pharmaceuticals Inc | $26.0M | NASDAQ | -3.1882 |
![Company Website](link.gif) | MRK ![Inactive Symbol](dead.gif) | Merck & Co., Inc. | $174.8B | NYSE | 3.1269 |
![Company Website](link.gif) | MBRX ![Inactive Symbol](dead.gif) | Moleculin Biotech Inc | $13.9M | NASDAQ | 5.7208 |
![Company Website](link.gif) | MYL ![Inactive Symbol](dead.gif) | Mylan NV | $19.8B | NASDAQ | 1.7764 |
![Company Website](link.gif) | NAII ![Inactive Symbol](dead.gif) | Natural Alternatives International, Inc. | $67.0M | NASDAQ | 4.8106 |
![Company Website](link.gif) | NEOS ![Inactive Symbol](dead.gif) | Neos Therapeutics Inc | $121.3M | NASDAQ | -1.9883 |
![Company Website](link.gif) | NEOT ![Inactive Symbol](dead.gif) | Neothetics Inc | $29.7M | NASDAQ | 7.1234 |
![Company Website](link.gif) | CUR ![Inactive Symbol](dead.gif) | Neuralstem, Inc. | $47.7M | NASDAQ | -8.6962 |
![Company Website](link.gif) | NVS ![Inactive Symbol](dead.gif) | Novartis AG (ADR) | $190.7B | NYSE | 3.3441 |
![Company Website](link.gif) | NVO ![Inactive Symbol](dead.gif) | Novo Nordisk A/S (ADR) | $80.0B | NYSE | 2.8662 |
![Company Website](link.gif) | OPK ![Inactive Symbol](dead.gif) | Opko Health Inc. | $4.0B | NASDAQ | 3.6819 |
![Company Website](link.gif) | PCRX ![Inactive Symbol](dead.gif) | Pacira Pharmaceuticals Inc | $1.9B | NASDAQ | 6.7727 |
| PTHN ![Inactive Symbol](dead.gif) | Patheon NV | $3.7B | NYSE | 1.1773 |
![Company Website](link.gif) | PTX ![Inactive Symbol](dead.gif) | Pernix Therapeutics Holdings Inc | $55.6M | NASDAQ | -1.0909 |
![Company Website](link.gif) | PFE ![Inactive Symbol](dead.gif) | Pfizer Inc. | $197.1B | NYSE | 2.0001 |
![Company Website](link.gif) | SGNT ![Inactive Symbol](dead.gif) | Sagent Pharmaceuticals Inc | $346.4M | NASDAQ | 2.9821 |
![Company Website](link.gif) | SNY ![Inactive Symbol](dead.gif) | Sanofi SA (ADR) | $62.5B | NYSE | 1.2416 |
![Company Website](link.gif) | SCLN ![Inactive Symbol](dead.gif) | SciClone Pharmaceuticals, Inc. | $484.4M | NASDAQ | 11.9424 |
![Company Website](link.gif) | SCYX ![Inactive Symbol](dead.gif) | SCYNEXIS Inc | $43.6M | NASDAQ | -2.0495 |
![Company Website](link.gif) | SHPG ![Inactive Symbol](dead.gif) | Shire PLC (ADR) | $54.8B | NASDAQ | 1.1519 |
![Company Website](link.gif) | SPHS ![Inactive Symbol](dead.gif) | Sophiris Bio Inc | $77.2M | NASDAQ | |
![Company Website](link.gif) | TARO ![Inactive Symbol](dead.gif) | Taro Pharmaceutical Industries Ltd. | $4.9B | NYSE | 14.1186 |
![Company Website](link.gif) | TLGT ![Inactive Symbol](dead.gif) | Teligent Inc | $471.0M | NASDAQ | 2.8297 |
![Company Website](link.gif) | TTPH ![Inactive Symbol](dead.gif) | Tetraphase Pharmaceuticals Inc | $291.0M | NASDAQ | 12.9052 |
![Company Website](link.gif) | TEVA ![Inactive Symbol](dead.gif) | Teva Pharmaceutical Industries Ltd (ADR) | $32.2B | NYSE | 0.7429 |
![Company Website](link.gif) | TBPH ![Inactive Symbol](dead.gif) | Theravance Biopharma Inc | $1.8B | NASDAQ | 3.6204 |
![Company Website](link.gif) | UG ![Inactive Symbol](dead.gif) | United-Guardian, Inc. | $64.7M | NASDAQ | 39.9583 |
![Company Website](link.gif) | VRX ![Inactive Symbol](dead.gif) | Valeant Pharmaceuticals Intl Inc | $4.6B | NYSE | 0.1644 |